Top compounds associated with response to NUAK1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.07
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.073 0.07
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.1 0.08
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.065 0.08
mRNA barasertib CTRPv2 pan-cancer AAC -0.062 0.08
mRNA SL 0101-1 GDSC1000 pan-cancer AAC -0.072 0.08
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.061 0.08
mRNA ML210 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA canertinib CTRPv2 pan-cancer AAC -0.069 0.08
Download CSV